Medicare 2027 Shake-Up: New Rules for Advantage, Drugs, and Plans
Published Date: 11/28/2025
Proposed Rule
Summary
Starting in 2027, Medicare Advantage, Prescription Drug, and Cost Plan programs will see updates to improve how plans are rated, marketed, and how drugs are covered. These changes affect millions of Medicare users and the companies that run these plans, aiming to make enrollment easier and benefits clearer. Comments on these updates are open until January 26, 2026, so stakeholders can weigh in before the new rules take effect.
Analyzed Economic Effects
6 provisions identified: 3 benefits, 0 costs, 3 mixed.
Part D redesign: $2,000 OOP and three phases
Medicare Part D is being changed to a three-phase benefit: deductible, initial coverage (25% coinsurance), and catastrophic with $0 cost sharing. The annual out-of-pocket (OOP) threshold was set at $2,000 for 2025 and was $2,100 for 2026; for 2026 and later years the OOP threshold will increase each year by the annual percentage increase and be rounded to the nearest $50.
No deductible for vaccines and capped insulin cost
The Part D deductible does not apply to ACIP-recommended adult vaccines and covered insulin products. For 2023–2025, the one-month cost-sharing amount for covered insulin products was $35; for 2026 and subsequent years the applicable cost-sharing amount for a one-month supply of covered insulin is the lesser of (1) $35, (2) 25% of the maximum fair price (MFP) for the insulin, or (3) 25% of the negotiated price.
Manufacturer Discount Program replaces Coverage Gap
The rule would codify the Manufacturer Discount Program, which replaced the Coverage Gap Discount Program and began on January 1, 2025. Under the Manufacturer Discount Program, manufacturers that enter agreements are required to provide discounts on applicable drugs in both the initial and catastrophic coverage phases. The Coverage Gap Discount Program agreements are proposed to be terminated effective January 1, 2025.
Marketing and agent rules changing Oct 1, 2026
CMS proposes revisions to marketing and communications rules applicable to contract year 2027 marketing beginning October 1, 2026. Proposed changes include modifying the definition and oversight of third-party marketing organizations (TPMOs), changing the 5 percent translation requirement, removing approval requirement for Medicare Card images, eliminating Outbound Enrollment Verification, modifying testimonial requirements, and removing certain mailing statement requirements. CMS seeks comments on enforcement and on using data or AI for oversight.
Changes to TrOOP, reinsurance, and Selected Drug rules
The proposed rule would codify updates to what payments count as True Out-Of-Pocket (TrOOP), establish how costs for drugs not subject to the Part D deductible count toward eligibility for manufacturer discounts under the Manufacturer Discount Program, and update the methodology for CMS reinsurance payments to Part D sponsors and implement the Selected Drug Subsidy.
Simplifying Star Ratings; no Health Equity reward
CMS proposes changes to simplify and refocus the Star Ratings measure set, proposes not to implement the Health Equity Index (also called Excellent Health Outcomes for All) reward, and would continue to include the historical reward factor in the Star Ratings methodology. CMS is soliciting comments on further simplification of Star Ratings.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-22792, Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program
Starting in 2029, Medicare will negotiate drug prices to help lower costs for people using Medicare Part D. This new rule, effective December 5, 2026, sets clear policies to make prescription drugs more affordable and fair. If you or a loved one uses Medicare for prescriptions, expect some savings and changes in how drug prices are set.
2026-22750, Calendar Year 2027 Home Health Prospective Payment System (HH PPS) Rate Update; Requirements for the HH Quality Reporting Program and the Expanded HH Value-Based Purchasing Model; Medicare Provider Enrollment, Durable Medical Equipment (DME), and DME, Prosthetics, Orthotics, and Supplies (DMEPOS) Policies
Starting in 2027, Medicare is updating how it pays home health agencies, including new payment rates and rules to make care better and fairer. Home health providers, equipment suppliers, and Medicare enrollees will see changes in payment methods, quality reporting, and equipment rules, with some new deadlines and expanded benefits. These updates aim to improve care quality while keeping payments clear and fair.
2026-22743, Medicare and Medicaid Programs; CY 2027 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program
Starting January 1, 2027, Medicare and Medicaid are updating how doctors and clinics get paid to better match real medical work and new laws. This includes new rules for drug price rebates, sharing savings programs, and payment updates for rural clinics and ambulance services. These changes affect doctors, patients, and healthcare providers, aiming to keep care fair, affordable, and up-to-date.
2026-22739, Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems; and Quality Reporting Programs; including the Hospital Outpatient Quality Reporting Program and Ambulatory Surgical Center Quality Program; Request for Information on Strengthening the Standardization and Comparability of Hospital Price Transparency (HPT) Data; Prior Authorization; Accrediting Organization (AO) Deeming for Emergency Medical Treatment and Labor Act (EMTALA); and Notices of Closure of Teaching Hospitals and Opportunities To Apply for Available Slots
Starting in 2027, Medicare is updating how hospitals and surgery centers get paid for outpatient care and surgeries. These changes affect hospitals, surgery centers, and patients by adjusting payment rates and improving quality reporting. Plus, CMS is asking for ideas to make hospital price info clearer and easier to compare, while also handling rules about emergency care and teaching hospital closures.
2026-22381, Medicare and Medicaid Programs; Organ Procurement Organizations Conditions for Coverage: Revisions to the Conditions for Coverage
This new rule updates how Organ Procurement Organizations (OPOs) operate to help get more life-saving organs to people who need transplants. It changes some definitions, competition rules, and appeal processes to make OPOs work better and be held accountable. These changes start January 4, 2027, and aim to save more lives without adding extra costs.
2026-22194, Medicare Program; CY 2027 Changes to the End-Stage Renal Disease (ESRD) Prospective Payment System, Acute Kidney Injury (AKI) Dialysis Payment, and ESRD Quality Incentive Program
Starting January 1, 2027, Medicare is updating how it pays for kidney dialysis treatments for people with End-Stage Renal Disease (ESRD) and those with Acute Kidney Injury (AKI). These changes include new payment rates and updated quality rules to make sure patients get the best care. If you’re a dialysis provider or patient, expect some shifts in payments and quality standards that aim to improve treatment and support innovation.
Previous / Next Documents
Previous: 2025-21437, Airworthiness Directives; Airbus Helicopters
If you fly Airbus Helicopters models AS332C, AS332C1, AS332L, AS332L1, or AS332L2, listen up! The FAA wants you to replace and upgrade parts in the main rotor to stop a dangerous part from breaking. You’ll need to act before January 12, 2026, or risk safety issues—and yes, there might be some costs involved to keep your chopper flying safe and sound.
Next: 2025-21495, Airworthiness Directives; Airbus Helicopters
If you fly or fix Airbus EC120B helicopters, listen up! The FAA wants you to check the pilot cyclic stick’s bonding braid because it might be in the wrong spot, making it hard to control the helicopter. You’ll need to inspect and fix it if needed, all to keep flights safe. Comments on this rule are open until January 12, 2026, so don’t wait to weigh in!